$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 31 32 33 34 35 36 37 38 39 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.00 | 550 | 38,500 | 41,495 | 42 K to 41.5 K (-1.31 %) |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.50 | 30 | 2,115 | 42,045 | 42.1 K to 42 K (-0.07 %) |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.75 | 1,000 | 70,750 | 42,075 | 43.1 K to 42.1 K (-2.32 %) |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 71.10 | 1,970 | 140,067 | 43,075 | 45 K to 43.1 K (-4.37 %) |
| Feb 02 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 20,650 | 280,892 | 45,045 | 24.4 K to 45 K (+84.65 %) |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | A | 65.58 | 35,000 | 2,295,300 | 35,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | Meyers James R | SVP Comm Ops North ... | Option Exercise | A | 65.58 | 28,000 | 1,836,240 | 28,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | A | 65.58 | 300,000 | 19,674,000 | 300,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | A | 65.58 | 130,000 | 8,525,400 | 130,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | A | 65.58 | 140,000 | 9,181,200 | 140,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 65.58 | 130,000 | 8,525,400 | 130,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | A | 65.58 | 50,000 | 3,279,000 | 50,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | CARACCIOLO ANTHONY | SVP, Manufacturing | Option Exercise | A | 65.58 | 40,000 | 2,623,200 | 40,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | A | 65.58 | 40,000 | 2,623,200 | 40,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | Montgomery Alan Bruce | SVP, Respiratory Th ... | Option Exercise | A | 65.58 | 20,000 | 1,311,600 | 20,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | A | 65.58 | 40,000 | 2,623,200 | 40,000 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | A | 65.58 | 40,000 | 2,623,200 | 40,000 | |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 6,500 | 31,078 | 49,000 | |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.52 | 1,100 | 70,972 | 9,000 | 10.1 K to 9 K (-10.89 %) |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.51 | 394 | 25,417 | 10,100 | 10.5 K to 10.1 K (-3.75 %) |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.44 | 100 | 6,444 | 10,494 | 10.6 K to 10.5 K (-0.94 %) |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.43 | 1,000 | 64,430 | 10,594 | 11.6 K to 10.6 K (-8.63 %) |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.35 | 606 | 38,996 | 11,594 | 12.2 K to 11.6 K (-4.97 %) |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 64.25 | 3,300 | 212,025 | 12,200 | 15.5 K to 12.2 K (-21.29 %) |
| Jan 12 2007 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 4.78 | 6,500 | 31,078 | 15,500 | 9 K to 15.5 K (+72.22 %) |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | A | 64.25 | 136 | 8,738 | 136 | |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | HILLS CARLA A | Director | Option Exercise | A | 65.58 | 30,000 | 1,967,400 | 30,000 | |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 3,550 | 48,289 | 45,512 | |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.63 | 300 | 19,089 | 24,395 | 24.7 K to 24.4 K (-1.21 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.87 | 300 | 19,161 | 24,695 | 25 K to 24.7 K (-1.20 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.07 | 500 | 32,035 | 24,995 | 25.5 K to 25 K (-1.96 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.18 | 500 | 32,090 | 25,495 | 26 K to 25.5 K (-1.92 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.50 | 200 | 12,900 | 25,995 | 26.2 K to 26 K (-0.76 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.00 | 750 | 48,750 | 26,195 | 26.9 K to 26.2 K (-2.78 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.25 | 500 | 32,625 | 26,945 | 27.4 K to 26.9 K (-1.82 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.45 | 500 | 32,725 | 27,445 | 27.9 K to 27.4 K (-1.79 %) |
| Jan 05 2007 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 3,550 | 48,289 | 27,945 | 24.4 K to 27.9 K (+14.55 %) |
| Jan 11 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 280,392 | |
| Jan 11 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.32 | 14,000 | 914,465 | 737,629 | 751.6 K to 737.6 K (-1.86 %) |
| Jan 11 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.31 | 10,000 | 653,139 | 751,629 | 761.6 K to 751.6 K (-1.31 %) |
| Jan 11 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.39 | 11,000 | 719,248 | 761,629 | 772.6 K to 761.6 K (-1.42 %) |
| Jan 11 2007 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 772,629 | 737.6 K to 772.6 K (+4.74 %) |
| Dec 22 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 7.40 | 4,000 | 29,594 | 0 | |
| Dec 22 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 7.40 | 4,000 | 29,594 | 4,000 | 0 to 4 K |
| Dec 22 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.08 | 4,060 | 28,737 | 0 | |
| Dec 22 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.08 | 4,060 | 28,737 | 103,301 | 99.2 K to 103.3 K (+4.09 %) |
| Dec 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 315,392 | |
| Dec 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.40 | 5,000 | 326,999 | 737,629 | 742.6 K to 737.6 K (-0.67 %) |
| Dec 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.47 | 10,000 | 654,653 | 742,629 | 752.6 K to 742.6 K (-1.33 %) |
| Dec 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.56 | 10,000 | 655,631 | 752,629 | 762.6 K to 752.6 K (-1.31 %) |
| Dec 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 65.60 | 10,000 | 656,022 | 762,629 | 772.6 K to 762.6 K (-1.29 %) |
| Dec 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 772,629 | 737.6 K to 772.6 K (+4.74 %) |
| Dec 04 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Gift | G | 0.00 | 15,400 | 0 | 59,600 | 75 K to 59.6 K (-20.53 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 1,200 | 16,323 | 49,062 | |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 3,550 | 48,289 | 50,262 | |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.00 | 1,200 | 80,400 | 24,395 | 25.6 K to 24.4 K (-4.69 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 1,200 | 16,323 | 25,595 | 24.4 K to 25.6 K (+4.92 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.25 | 1,000 | 64,250 | 24,395 | 25.4 K to 24.4 K (-3.94 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.75 | 1,000 | 64,750 | 25,395 | 26.4 K to 25.4 K (-3.79 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.00 | 500 | 32,500 | 26,395 | 26.9 K to 26.4 K (-1.86 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.40 | 500 | 32,700 | 26,895 | 27.4 K to 26.9 K (-1.83 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 66.20 | 550 | 36,410 | 27,395 | 27.9 K to 27.4 K (-1.97 %) |
| Dec 05 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 3,550 | 48,289 | 27,945 | 24.4 K to 27.9 K (+14.55 %) |
| Nov 27 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 3.27 | 20,000 | 65,314 | 0 | |
| Nov 27 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 3.27 | 20,000 | 65,314 | 58,399 | 38.4 K to 58.4 K (+52.08 %) |
| Nov 22 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 100 | 1,360 | 53,812 | |
| Nov 22 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 70.00 | 100 | 7,000 | 24,395 | 24.5 K to 24.4 K (-0.41 %) |
| Nov 22 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 100 | 1,360 | 24,495 | 24.4 K to 24.5 K (+0.41 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 26.73 | 30,000 | 801,900 | 0 | |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.29 | 265 | 18,097 | 1,735 | 2 K to 1.7 K (-13.25 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.30 | 100 | 6,830 | 2,000 | 2.1 K to 2 K (-4.76 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | S | 68.48 | 100 | 6,848 | 2,100 | 2 K to 2.1 K (+5.00 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.53 | 200 | 13,706 | 2,200 | 2.4 K to 2.2 K (-8.33 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.54 | 621 | 42,563 | 2,400 | 3 K to 2.4 K (-20.56 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.55 | 721 | 49,425 | 3,021 | 3.7 K to 3 K (-19.27 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.56 | 100 | 6,856 | 3,742 | 3.8 K to 3.7 K (-2.60 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.57 | 179 | 12,274 | 3,842 | 4 K to 3.8 K (-4.45 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.59 | 100 | 6,859 | 4,021 | 4.1 K to 4 K (-2.43 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.60 | 590 | 40,474 | 4,121 | 4.7 K to 4.1 K (-12.52 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.61 | 1,700 | 116,637 | 4,711 | 6.4 K to 4.7 K (-26.52 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.62 | 1,000 | 68,620 | 6,411 | 7.4 K to 6.4 K (-13.49 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.63 | 600 | 41,178 | 7,411 | 8 K to 7.4 K (-7.49 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.64 | 1,031 | 70,768 | 8,011 | 9 K to 8 K (-11.40 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.65 | 1,500 | 102,975 | 9,042 | 10.5 K to 9 K (-14.23 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.66 | 100 | 6,866 | 10,542 | 10.6 K to 10.5 K (-0.94 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.68 | 1,166 | 80,081 | 10,642 | 11.8 K to 10.6 K (-9.87 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.69 | 1,971 | 135,388 | 11,808 | 13.8 K to 11.8 K (-14.30 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.70 | 2,495 | 171,407 | 13,779 | 16.3 K to 13.8 K (-15.33 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.71 | 1,332 | 91,522 | 16,274 | 17.6 K to 16.3 K (-7.57 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.72 | 3,466 | 238,184 | 17,606 | 21.1 K to 17.6 K (-16.45 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.73 | 962 | 66,118 | 21,072 | 22 K to 21.1 K (-4.37 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.74 | 2,886 | 198,384 | 22,034 | 24.9 K to 22 K (-11.58 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.75 | 1,882 | 129,388 | 24,900 | 26.8 K to 24.9 K (-7.03 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.76 | 841 | 57,827 | 26,782 | 27.6 K to 26.8 K (-3.04 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.77 | 1,197 | 82,318 | 27,623 | 28.8 K to 27.6 K (-4.15 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.78 | 280 | 19,258 | 28,820 | 29.1 K to 28.8 K (-0.96 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.79 | 700 | 48,153 | 29,100 | 29.8 K to 29.1 K (-2.35 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.80 | 200 | 13,760 | 29,800 | 30 K to 29.8 K (-0.67 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 26.73 | 30,000 | 801,900 | 30,000 | 0 to 30 K |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.18 | 134 | 9,136 | 0 | 134 to 0 (-100.00 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.19 | 100 | 6,819 | 134 | 234 to 134 (-42.74 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.20 | 366 | 24,961 | 234 | 600 to 234 (-61.00 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.22 | 300 | 20,466 | 600 | 900 to 600 (-33.33 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 68.27 | 835 | 57,005 | 900 | 1.7 K to 900 (-48.13 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 9.81 | 30,000 | 294,300 | 0 | |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 11.76 | 2,528 | 29,724 | 0 | |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 9.34 | 4,000 | 37,375 | 0 | |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Gift | G | 0.00 | 200 | 0 | 4,034 | 4.2 K to 4 K (-4.72 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 69.06 | 600 | 41,436 | 12,839 | 13.4 K to 12.8 K (-4.46 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 69.05 | 800 | 55,240 | 13,439 | 14.2 K to 13.4 K (-5.62 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 69.02 | 300 | 20,706 | 14,239 | 14.5 K to 14.2 K (-2.06 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 69.00 | 10,700 | 738,300 | 14,539 | 25.2 K to 14.5 K (-42.39 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.98 | 700 | 48,286 | 25,439 | 26.1 K to 25.4 K (-2.68 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.97 | 200 | 13,794 | 26,139 | 26.3 K to 26.1 K (-0.76 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.96 | 5,300 | 365,488 | 26,339 | 31.6 K to 26.3 K (-16.75 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.94 | 300 | 20,682 | 31,639 | 31.9 K to 31.6 K (-0.94 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.93 | 600 | 41,358 | 31,939 | 32.5 K to 31.9 K (-1.84 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.92 | 2,871 | 197,869 | 32,539 | 35.4 K to 32.5 K (-8.11 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.91 | 2,474 | 170,483 | 35,410 | 37.9 K to 35.4 K (-6.53 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.90 | 361 | 24,873 | 37,884 | 38.2 K to 37.9 K (-0.94 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 68.89 | 11,122 | 766,195 | 38,245 | 49.4 K to 38.2 K (-22.53 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 9.81 | 30,000 | 294,300 | 49,367 | 19.4 K to 49.4 K (+154.90 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 11.76 | 2,528 | 29,724 | 19,367 | 16.8 K to 19.4 K (+15.01 %) |
| Nov 21 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 9.34 | 4,000 | 37,375 | 16,839 | 12.8 K to 16.8 K (+31.16 %) |
| Nov 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 350,392 | |
| Nov 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 66.66 | 8,000 | 533,261 | 737,629 | 745.6 K to 737.6 K (-1.07 %) |
| Nov 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 66.65 | 12,000 | 799,805 | 745,629 | 757.6 K to 745.6 K (-1.58 %) |
| Nov 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 66.67 | 5,000 | 333,348 | 757,629 | 762.6 K to 757.6 K (-0.66 %) |
| Nov 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 66.68 | 10,000 | 666,804 | 762,629 | 772.6 K to 762.6 K (-1.29 %) |
| Nov 16 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 772,629 | 737.6 K to 772.6 K (+4.74 %) |
| Nov 13 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 5.13 | 10,000 | 51,329 | 23,600 | |
| Nov 13 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 5.13 | 30,000 | 153,987 | 33,600 | |
| Nov 13 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 68.72 | 30,000 | 2,061,582 | 75,000 | 105 K to 75 K (-28.57 %) |
| Nov 13 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 5.13 | 10,000 | 51,329 | 105,000 | 95 K to 105 K (+10.53 %) |
| Nov 13 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 5.13 | 30,000 | 153,987 | 95,000 | 65 K to 95 K (+46.15 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 4,750 | 64,612 | 53,912 | |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.20 | 100 | 6,820 | 26,345 | 26.4 K to 26.3 K (-0.38 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.19 | 100 | 6,819 | 26,445 | 26.5 K to 26.4 K (-0.38 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.12 | 100 | 6,812 | 26,545 | 26.6 K to 26.5 K (-0.38 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.11 | 100 | 6,811 | 26,645 | 26.7 K to 26.6 K (-0.37 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.09 | 100 | 6,809 | 26,745 | 26.8 K to 26.7 K (-0.37 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.08 | 100 | 6,808 | 26,845 | 26.9 K to 26.8 K (-0.37 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.06 | 100 | 6,806 | 26,945 | 27 K to 26.9 K (-0.37 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.04 | 100 | 6,804 | 27,045 | 27.1 K to 27 K (-0.37 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.03 | 100 | 6,803 | 27,145 | 27.2 K to 27.1 K (-0.37 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.01 | 700 | 47,607 | 27,245 | 27.9 K to 27.2 K (-2.50 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 68.00 | 300 | 20,400 | 27,945 | 28.2 K to 27.9 K (-1.06 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.99 | 100 | 6,799 | 28,245 | 28.3 K to 28.2 K (-0.35 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.87 | 100 | 6,787 | 28,345 | 28.4 K to 28.3 K (-0.35 %) |
| Nov 03 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.70 | 100 | 6,770 | 28,445 | 28.5 K to 28.4 K (-0.35 %) |